1-11 of 11
Keywords: PMA
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Articles
Articles
Biochem J (2006) 395 (1): 117–123.
Published: 15 March 2006
... and an activator of novel PKC isoforms had no effect. PKC inhibitors (including the PKCα-preferring Ro 31-8280) reduced the inhibitory effect of the PKC-activating compounds. Microscopic analyses revealed a PMA-induced reduction in the cell-surface expression of fusion proteins between hCAT-3 and enhanced green...
Includes: Supplementary data
Articles
Biochem J (2006) 393 (1): 59–67.
Published: 12 December 2005
... and late endosomes, finally resulting in their endolysosomal degradation. PMA, EGF (epidermal growth factor), bafilomycin A1 and cycloheximide were obtained from Sigma (St. Louis, MO, U.S.A.). Anti-Cx43 antibodies were obtained by injecting rabbits with a synthetic peptide consisting of the 20 C-terminal...
Articles
Biochem J (2005) 388 (2): 527–535.
Published: 24 May 2005
...Hye Jin YOU; Chang-Hoon WOO; Eun-Young CHOI; Sung-Hoon CHO; Yung Joon YOO; Jae-Hong KIM The roles of Rac and p38 kinase in the activation of cPLA 2 (cytosolic PLA 2 ) in Rat-2 fibroblasts were investigated. In the present study, we found that PMA activates cPLA 2 by a Rac-p38 kinase-dependent...
Articles
Biochem J (2003) 372 (2): 529–534.
Published: 01 June 2003
... (IGF-1), dexamethasone, thyroid hormones and PMA was studied. HepG2 cells were transfected transiently with luciferase reporter gene constructs containing DNA fragments flanking the 5′-region of the human CYP27A1 gene. GH, IGF-1 and dexamethasone increased the promoter activity by 2–3-fold, whereas...
Articles
Articles
Articles
Articles
Articles
Biochem J (1999) 344 (3): 921–928.
Published: 08 December 1999
... of 1,25(OH) 2 D 3 but had no effect on the IFN-γ-mediated increase in activity of sphingomyelinase. Isoform-specific antibodies were used to deplete different PKC isoforms from cytosol before the treatment of the cytosolic fraction with 1,25(OH) 2 D 3 , arachidonic acid (AA) and PMA. The depletion of PKC...